Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SUMO2 pseudogene 7 is a genomic DNA sequence similar to the functional *SUMO2* gene (small ubiquitin-like modifier 2) but lacks the ability to express a functional protein. The SUMO2 pseudogenes, including SUMO2P7, do not participate in cellular sumoylation pathways or other protein functions. They are distinguished from protein-coding genes like *SUMO2*, which is involved in nuclear transport, transcriptional regulation, apoptosis, DNA repair, and protein stability[3][4]. The presence of pseudogenes such as SUMO2P7 is common in the human genome, often resulting from gene duplication or retrotransposition, but they do not have established biological or therapeutic relevance. In summary, **SUMO2 pseudogene 7 (SUMO2P7)** is not a protein-coding gene or a therapeutic/molecular target; it is a non-functional genomic sequence and should not be considered for research or drug targeting purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SUMO2 pseudogene 7 (SUMO2P7).